Immatics (IMTX) EBT Margin (2019 - 2025)

Immatics (IMTX) reported EBT Margin of 179.97% for Q4 2025, down 25689.0% on a YoY basis from N/an in Q4 2024, and up 81.58% sequentially from 976.9% in Q3 2025.

Immatics (IMTX) EBT Margin (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of EBT Margin data on file, last reported at 179.97% in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin fell 25689.0% year-over-year to 179.97%; the trailing twelve-month figure through Dec 2025 stood at 415.69% (down 42906.0% YoY), and the FY2025 full-year result was 411.13%, down 42483.0% from the prior year.
  • EBT Margin grew to 179.97% in Q4 2025, from 976.9% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 83.24% in Q1 2022 to a low of 1506.21% in Q2 2025.
  • A 5-year average of 266.86% and a median of 149.77% in 2022 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin surged 166083 bps in 2021 and slumped 141102 bps in 2025, its largest moves.
  • Tracing IMTX's EBT Margin over 5 years: stood at 106.74% in 2021, then jumped by 74 bps to 27.66% in 2022, then slumped by 494 bps to 164.24% in 2023, then surged by 147 bps to 76.92% in 2024, then sank by 334 bps to 179.97% in 2025.
  • Business Quant data shows IMTX's EBT Margin at 179.97% in Q4 2025, 976.9% in Q3 2025, and 1506.21% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -179.97%

Historic Data

Download Data
DateValue
Dec 31, 2025 -179.97%
Sep 30, 2025 -976.90%
Jun 30, 2025 -1,506.21%
Mar 31, 2025 -219.83%
Dec 31, 2024 76.92%
Sep 30, 2024 -4.65%
Jun 30, 2024 -95.19%
Mar 31, 2024 -5.69%
Dec 31, 2023 -164.24%
Sep 30, 2023 -447.00%
Jun 30, 2023 -110.09%
Mar 31, 2023 -201.58%
Dec 31, 2022 -27.66%
Sep 30, 2022 -135.31%
Jun 30, 2022 -74.56%
Mar 31, 2022 83.24%
Dec 31, 2021 -106.74%
Sep 30, 2021 -422.21%
Jun 30, 2021 -511.35%
Mar 31, 2021 -308.16%